# Anti-Inflammatory Pulmonal Therapy of CF-Patients With Amitriptyline and Placebo

> **NCT00515229** · PHASE2 · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 18 (actual)

## Conditions studied

- Cystic Fibrosis
- Infection
- Pseudomonas Aeruginosa

## Interventions

- **DRUG:** amitriptyline

## Key facts

- **NCT ID:** NCT00515229
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2007-08-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00515229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00515229, "Anti-Inflammatory Pulmonal Therapy of CF-Patients With Amitriptyline and Placebo". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00515229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*